Sanford Center for Biobehavioral Research, Fargo, North Dakota, USA.
Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Int J Eat Disord. 2021 Jul;54(7):1289-1294. doi: 10.1002/eat.23531. Epub 2021 May 5.
To replicate findings from a prior study which identified prospective associations between use of products for weight control and subsequent receipt of a first-time eating disorder (ED) diagnosis among female adolescents and young adults.
Data from a prospective cohort study, Project EAT (Eating and Activity in Teens and Young Adults), were used to examine prospective associations between self-reported past-year diet pill and laxative use for weight control and self-reported receipt of an ED diagnosis among females without prior receipt of an ED diagnosis (N = 1,015). Participants were followed from early/middle adolescence (EAT-I; M = 14.9 years) into late adolescence/emerging adulthood (EAT-II; M = 19.5 years) and young adulthood (EAT-III; M = 24.8 years).
First-time receipt of an ED diagnosis was reported by 2.4% of participants at EAT-II and 4.0% at EAT-III. After adjusting for demographics and weight status, participants using diet pills (risk ratio [RR] = 3.58, 95% confidence interval [CI]: 1.96-6.54) and laxatives (RR = 2.77, 95% CI: 1.01-7.64) had greater risk of receiving a first-time ED diagnosis within 5 years than those not using these products.
The present study replicated prior findings, providing further evidence for a prospective link between use of products for weight control and subsequent receipt of an ED diagnosis.
复制先前的一项研究结果,该研究确定了女性青少年和年轻成年人使用体重控制产品与随后首次被诊断为饮食失调症(ED)之间存在前瞻性关联。
本研究使用了一项前瞻性队列研究项目 EAT(青少年和年轻成年人的饮食和活动)的数据,调查了过去一年中自我报告的减肥药和泻药用于体重控制的使用情况与之前未被诊断为 ED 的女性中自我报告的 ED 诊断之间的前瞻性关联(N=1015)。参与者从青少年早期/中期(EAT-I;M=14.9 岁)到青少年晚期/成年早期(EAT-II;M=19.5 岁)和成年早期(EAT-III;M=24.8 岁)进行随访。
在 EAT-II 和 EAT-III 中,分别有 2.4%和 4.0%的参与者首次报告被诊断为 ED。在调整人口统计学和体重状况后,使用减肥药(风险比 [RR]=3.58,95%置信区间 [CI]:1.96-6.54)和泻药(RR=2.77,95% CI:1.01-7.64)的参与者在 5 年内被诊断为 ED 的风险高于未使用这些产品的参与者。
本研究复制了先前的发现,进一步证明了使用体重控制产品与随后被诊断为 ED 之间存在前瞻性关联。